EN
中文 EN
Newsroom
Company News
Media Report
Company News
More
2025-03-21
Professor Adrian V. S. Hill FRS from Oxford University Visits CanSinoBIO, Highlights Vaccine Innovations
CanSinoBIO Obtained Approval for Clinical Trials on Inhaled TB Vaccine in Indonesia
2025-05-15
SPIMACO and CanSinoBIO Sign an Agreement to Localise and Market the MCV4 Vaccine in Saudi Arabia and MENA
2025-03-26
CanSinoBIO Obtained Approval for Clinical Trials on DTcP-Hib-MCV4 Combined Vaccine
2025-02-24
CanSinoBIO Announces Priority Review Status for DTcP Infant
2025-02-07
CanSinoBIO Obtained Halal Decree of Menhycia® in Indonesia
2025-02-06
Media Report
More
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Time：2025-03-28
More
CanSinoBIO to Showcase China’s Vaccine Innovation at 2025 World Government Summit in Dubai
Time：2025-02-14
More
CanSinoBIO Secures Further Funding from the Bill & Melinda Gates Foundation
Time：2024-10-09Source：ACN Newswire
More